| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.7M | +154.1% |
| R&D Expense | $74.3M | -10.4% |
| SG&A Expense | $19.3M | -8.4% |
| Operating Income | -$92.0M | +11.0% |
| Income Tax | $0 | — |
| Net Income | -$87.3M | +14.4% |
| EPS (Basic) | -$2.05 | +14.9% |
| EPS (Diluted) | -$2.05 | +14.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $125.6M | +165.2% |
| Current Assets | $143.2M | -22.4% |
| Total Assets | $159.6M | -22.3% |
| Current Liabilities | $11.5M | -54.1% |
| Total Liabilities | $14.9M | -49.1% |
| Stockholders' Equity | $144.7M | -17.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$81.2M | +14.0% |
| Capital Expenditures | $407K | -96.5% |
| Investing Cash Flow | $110.9M | +124.2% |
| Financing Cash Flow | $48.6M | — |
| Free Cash Flow | -$81.6M | +23.1% |